Commonwealth of Pennsylvania Public School Employees Retirement System’s Aspire Biopharma Warrant ASBPW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-12,500
Closed -$1K 1820
2022
Q3
$1K Buy
+12,500
New +$1.82K ﹤0.01% 1878

Other funds holding ASBPW

Commonwealth of Pennsylvania Public School Employees Retirement System's ASBPW Position: Q4 2022 in Review

Commonwealth of Pennsylvania Public School Employees Retirement System sold out of Aspire Biopharma Warrant (ASBPW) in Q4 2022, closing a stake of 12,500 shares — an estimated $1K sold.

Commonwealth of Pennsylvania Public School Employees Retirement System first reported a position in ASBPW in Q3 2022 and held it in 1 quarter. The position peaked at $1K in Q3 2022. 36 funds tracked by Wall St. Rank hold ASBPW as of Q4 2022.

  • Commonwealth of Pennsylvania Public School Employees Retirement System reported no remaining Aspire Biopharma Warrant position as of Q4 2022 after selling out during the quarter.
  • Commonwealth of Pennsylvania Public School Employees Retirement System sold 12,500 Aspire Biopharma Warrant shares in Q4 2022, an estimated $1K.
  • Commonwealth of Pennsylvania Public School Employees Retirement System first reported a position in Aspire Biopharma Warrant in Q3 2022 and held it in 1 quarter.
  • Commonwealth of Pennsylvania Public School Employees Retirement System's Aspire Biopharma Warrant position peaked at $1K in Q3 2022.
  • 36 funds tracked by Wall St. Rank held Aspire Biopharma Warrant as of Q4 2022.

Based on Commonwealth of Pennsylvania Public School Employees Retirement System's 13F filing for Q4 2022, filed 13 Feb 2023.